US EditionA better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials | Medicines Law & Policy
Summary by medicineslawandpolicy.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials | Medicines Law & Policy
Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million lives lost a year by 2050. In the European Union alone, it is the cause of 35,000 deaths a year, and this number is also expected to increase. Decisive action is needed to avert this growing threat to public health. A major challenge is that the current model for medicines development is not well suited to incen…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage